PET TUMOR IMAGING

DATE: 12/22/2005

PROCEDURE:  Following IV injection of 18-fluoro-2-deoxyglucose (FDG) and a standard uptake period, the patient was imaged on a Siemens/CTI PET scanner.  Multiple six-minute bed position acquisitions were obtained along the length of the patient's body from the mid thigh to the base of the skull.  

FDG DOSE: [15] mCi

SESSION NUMBER: p00000

CORRELATIVE STUDIES: None

COMPARISON: None

CLINICAL HISTORY: The patient is a [...]-year-old [fe]male with past medical history significant for [...], who is referred for evaluation of [...].

FINDINGS: 

Normal metabolic activity is noted within the head and neck musculature, myocardium, liver, spleen, gastrointestinal tract, bilateral kidneys, urinary bladder and visualized axial and appendicular skeleton.

No focus of abnormal metabolic activity is seen.

Normal metabolic activity is seen throughout the cortical structures bilaterally, basal ganglia, thalami and the cerebellum. The interhemispheric, interthalamic, intercaudate and intersulcal distances are within normal limits.

CONCLUSIONS:  

1. PET scan without evidence of hypermetabolic malignant disease.

2. No other focus of abnormally increased metabolic activity is visualized.

1. The focus of increased tracer activity in the bowel most likely represent normal bowel activity; however, given the focality and intensity, malignant processes cannot be entirely excluded.

Thank you for referring this patient to the UCLA Nuclear Medicine Clinic.

I, [...], M.D., Ph.D., have reviewed this Nuclear Medicine study personally, and am in full agreement with the findings of the report presented here.